25 million U.S. Dollars for International Cancer Research

- EN - DE
Martin Eilers has received $25 million in funding for his research. In the foreg
Martin Eilers has received $25 million in funding for his research. In the foreground: employee Katrin Trunk, who will play a key role in the project. (Eilers/JMU, laterally extended with Firefly) (Image: Eilers/JMU)
Cancer is one of the most common causes of death in children worldwide. A research team in which the University of Würzburg is involved wants to change this - and has now received substantial funding for its work.

The team is co-led by Martin Eilers, Chair of Biochemistry and Molecular Biology at the University of Würzburg (JMU). "Our research project is called KOODAC," he explains. "That stands for ’Knocking-Out Oncogenic Drivers and Curing Childhood Cancer’". Our goal is to develop well-tolerated drugs that can target and eliminate cancer cells in children." The current standard of care for childhood cancer is chemotherapy and radiation therapy, which, even when successful, are associated with severe side effects. ...
account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.

Register


Login


Subscribe